Abstract
Minimum bactericidal concentrations (MBCs) for ciprofloxacin were significantly higher among 41 members of the H30 subclone within Escherichia coli sequence type 131 than among 48 other fluoroquinolone-resistant E. coli isolates. This MBC difference, which was not explained by ciprofloxacin MICs, gyrA, parC, and parE mutations, the presence of aac(6')-Ib-cr, or organic solvent tolerance (a surrogate for efflux pump activity), conceivably could have promoted the pandemic emergence of the H30 sequence type 131 subclone.
References
May 1, 1989·Antimicrobial Agents and Chemotherapy·J S WolfsonM N Swartz
Mar 25, 1998·The Journal of Antimicrobial Chemotherapy·M OethingerS B Levy
Dec 3, 1998·Antimicrobial Agents and Chemotherapy·T J Falla, I Chopra
Mar 29, 2005·Antimicrobial Agents and Chemotherapy·C WiuffB R Levin
Dec 22, 2005·Nature Medicine·Ari RobicsekDavid C Hooper
Jun 15, 2007·Journal of Clinical Microbiology·Antonio SorlozanoJosé Luis Martínez
Oct 2, 2008·Emerging Infectious Diseases·Amee R MangesPierre-Paul Tellier
Oct 8, 2008·Antimicrobial Agents and Chemotherapy·Sonia K Morgan-LinnellLynn Zechiedrich
Sep 11, 2009·Journal of Clinical Microbiology·Peter T EnderJames R Johnson
Nov 18, 2009·Antimicrobial Agents and Chemotherapy·James R JohnsonJames Rice
Jun 25, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·James R JohnsonMariana Castanheira
Mar 16, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Deborah A WilliamsonJoshua T Freeman
Apr 4, 2012·Emerging Infectious Diseases·James R JohnsonUNKNOWN MASTER Investigators
Sep 28, 2012·Journal of Clinical Microbiology·Aris AssimacopoulosJames R Johnson
Jan 5, 2013·The Journal of Infectious Diseases·James R JohnsonEvgeni V Sokurenko
Mar 8, 2013·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Ritu BanerjeeJames R Johnson
Aug 9, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Aylin ColpanUNKNOWN VICTORY (Veterans Influence of Clonal Types on Resistance: Year 2011) Investigators
Oct 1, 2013·Genetics·Alyssa TheodoreMarin Vulic
Dec 19, 2013·MBio·Lance B PriceEvgeni V Sokurenko
Apr 8, 2014·Proceedings of the National Academy of Sciences of the United States of America·Nicola K PettyScott A Beatson
Jul 2, 2014·Clinical Microbiology Reviews·Marie-Hélène Nicolas-ChanoineJean-Yves Madec
May 20, 2015·Antimicrobial Agents and Chemotherapy·James R JohnsonVeronika Tchesnokova
Citations
Mar 31, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·James R JohnsonEvgeni Sokurenko
Mar 30, 2017·PloS One·Veronika TchesnokovaEvgeni V Sokurenko
Jul 3, 2019·Proceedings of the National Academy of Sciences of the United States of America·Veronika TchesnokovaEvgeni V Sokurenko
Mar 11, 2020·Antimicrobial Agents and Chemotherapy·Brian D JohnstonJames R Johnson
Mar 12, 2020·Frontiers in Microbiology·Miklos FuziAkos Toth
Jan 19, 2021·Journal of Global Antimicrobial Resistance·Brian D JohnstonJames R Johnson
Feb 13, 2021·Diagnostic Microbiology and Infectious Disease·Brian D JohnstonJames R Johnsona
Mar 7, 2021·Antibiotics·Maud de LagardeJohn Morris Morris Fairbrother
Jan 21, 2021·Antimicrobial Agents and Chemotherapy·Johannes CampWinfried V Kern
Jul 9, 2021·Infection and Drug Resistance·Na HuangLijiang Chen